Latest posts
-
Waaree Energies shares gain 2% after company bags 2 GW solar module order
Waaree Energies shares rose after securing a 2 GW solar module supply order from a leading domestic solar developer for FY27-FY28. The contract’s value remains undisclosed. Despite the order, the stock has declined recently and trades below seven of eight SMAs. FIIs raised their June-quarter stake, while mutual fund holdings fell.
-
Hindustan Copper shares gain 3% as company plans Rs 7,000 crore capital investment in next 5 years
Hindustan Copper shares rose after the company announced a Rs 7,000 crore investment over the next 5-6 years and signed MoUs with major PSUs to expand its mining portfolio, while also partnering with Chile’s CODELCO on mining expertise and capacity building.
-
Embassy Developments rallies 8% after Rs 711 crore residential tower deal with Angel One founder
Embassy Developments shares rallied up to 8% to Rs 63.80 after signing an MoU to sell an entire residential tower at Embassy Terazza in Juhu to Angel One CMD Dinesh Thakkar for Rs 711 crore. Spanning 63,000 sq ft, it is India’s largest single residential property transaction.
-
PI Industries Shares Gain As Company Receives Approval For In-House Discovered Insecticide Molecule
India has always been one of the world’s biggest users of crop protection chemicals but never a source of them; the underlying molecules have historically been discovered by multinational agrochemical majors abroad and simply licensed, formulated or manufactured here. Homegrown discovery research has been rare because it is punishingly expensive and slow, and Indian companies…
-
Long-duration debt funds offer 7.8% yields, but further rate hikes could hurt returns. What should investors do?
Long-duration debt funds offer yields of around 7.50-7.80%, but further rises in bond yields could trigger mark-to-market losses. Experts explain whether investors should lock in current yields or consider shorter-duration options.
-
Symbiotec Shares Drop 6% After Weak Q1: Here’s What Investors Should Watch
This Newly Listed Stock, engaged in manufacturing APIs, nutritional ingredients, specialty products, steroidal hormones, and biotechnology-based products for pharmaceutical and global healthcare markets, is down 6.07 percent after reporting weak June quarterly results. Here’s what investors should watch next: margins, debt levels, new capacity, and future earnings growth. With a market capitalization of Rs. 7,515.72…
-
Lessons from Nepal floods: What Indian businesses need to know about disaster insurance
Nepal floods caused $2.56 billion in losses and $171 million in insurance claims, exposing risks relevant to India, which loses $8 billion annually to disasters. Sikkim’s 2023 GLOF disaster showed how sub-limits can leave ‘All Risk’ policies dangerously underinsured.
-
The price of innovation: why UPI needs revenue to stay free
As UPI enters a new phase of scale, a 0.4% MDR on larger merchant payments aims to fund infrastructure, cybersecurity and innovation while keeping most transactions free.
-
Meesho shares rally 12% after UBS hikes target price by 24%. What’s keeping analysts bullish?
UBS has raised its Meesho estimates across NMV, contribution profit and EBITDA, citing stronger seller and buyer growth and improving unit economics. The brokerage expects contribution margins to expand as logistics costs ease and advertising revenue grows. Meesho’s ability to sustain user additions, ordering frequency and NMV growth remains central to its outlook.
-
HDFC Bank shares hit 7-week high as RBI weighs Anup Bagchi for CEO post. What lies ahead?
HDFC Bank shares rose to a nearly seven-week high of Rs 749.30, extending gains to 5% over three sessions, after ET reported that the RBI is weighing Anup Bagchi’s candidature for the bank’s CEO and MD post and has sought feedback from IRDAI and ICICI Bank CEO Sandeep Bakhshi.